Corrigendum: Triplebody Mediates Increased Anti-Leukemic Reactivity of IL-2 Activated Donor Natural Killer (NK) Cells and Impairs Viability of Their CD33-Expressing NK Subset

Detalles Bibliográficos
Autores principales: Kloess, Stephan, Ede Valverde da Silva, Alessa, Oberschmidt, Olaf, Gardlowski, Tanja, Matthies, Nadine, Vyas, Maulik, Arseniev, Lubomir, Heuser, Michael, Pogge von Strandmann, Elke, Köhl, Ulrike
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6187021/
https://www.ncbi.nlm.nih.gov/pubmed/30344526
http://dx.doi.org/10.3389/fimmu.2018.02326

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6187021/
https://www.ncbi.nlm.nih.gov/pubmed/30344526
http://dx.doi.org/10.3389/fimmu.2018.02326

Ejemplares similares